Home / News / Global Next Generation Sequencing Market is expected to grow at the CAGR of 21.2% during 2015-2022 – Brisk Insights

Global Next Generation Sequencing Market is expected to grow at the CAGR of 21.2% during 2015-2022 – Brisk Insights

According to a recently published report, the Next Generation Sequencing Market is expected to grow by 21.2% CAGR during 2015-2022. The segmentation of global next generation sequencing market is based on end user, application, product & services, technology and geography. The report on global next generation sequencing market forecast 2015-2022 (by end user, application, product & services, technology and geography) provides detailed overview and predictive analysis of the market.

Full report is available on global next generation sequencing market forecast, 2015-2022 (by end user, application, product & services, technology and geography) report at http://www.briskinsights.com/report/next-generation-sequencing-market

The global next generation sequencing market has been estimated to grow with and impressive rate in the forecasted period. There are number of factors driving the market positively such as technological advancement in the products of NGS, widening application of the NGS, escalating incidences of next generation sequencing, the enhanced management &control of next generation sequencing etc.

Though the market is subject to the potential growth but yet it has to face the several restraints such as precision & standardization distresses in diagnostic testing and dearth of skilled professionals. The rising demand for the personalized medicine & biomarker discovery exposed are the key opportunities available in the global market. Various initiatives have been taken by different countries for the development of personalized medicines. In 2015,it has been announced that a country will be investing $215 million for the development of personalized medicines. The personalized medicines are used to cure so many diseases but the major share is hold by oncology i.e. of38%, psychiatry by 17%, infectious diseases by 10%, cardiology by 7%, Endocrinology by 6%, Neurology by 6%, gastroenterology by 5% and others accounts to 11%. The increasing use of personalized medicines has ultimately increased the scope of the market and at the same time creating huge & new opportunities forthe next generation sequencing in the global market.
Scope of the report

1. GLOBAL NEXT GENERATION SEQUENCING MARKET BY APPLICATION 2012-2022 ($ MILLION)
1.1 Agriculture& Animal Research
1.2 Biomarker Discovery
1.3 Diagnostics
1.4 Drug Discovery
1.5 Personalized Medicine
1.6 Other

2. GLOBAL NEXT GENERATION SEQUENCING MARKET BY END USER APPLICATION 2012-2022 ($ MILLION)
2.1. Hospitals & Clinics
2.2. Pharmaceutical & Biotechnology Companies
2.3. Research Centers And Academic & Government Institutes
2.4. Other

3. GLOBAL NEXT GENERATION SEQUENCING MARKET BY PRODUCT 2012-2022 ($ MILLION)
3.1. Pre-Sequencing Products & Services
3.1.1. DNA Fragmentation, End Repair, A-Tailing, And Size Selection
3.1.2. Library Preparation & Target Enrichment
3.1.3. Quality Control
3.2. NGS Platforms, Consumables, & Services For Platforms
3.3. Sequencing Services
3.3.1. Chip-Seq
3.3.2. De Novo Sequencing
3.3.3. Exome Sequencing
3.3.4. Methyl-Seq
3.3.5. Rna-Seq
3.3.6. Targeted Re-Sequencing
3.3.7. Whole-Genome Sequencing
3.3.8. Others
3.4. NGS Data Analysis, Storage, And Management (Bioinformatics)
3.4.1. NGS Data Analysis Services
3.4.2. NGS Data Analysis Software & Workbenches
3.4.3. NGS Storage, Management, And Cloud Computing Solutions

4. GLOBAL NEXT GENERATION SEQUENCING MARKET BY TECHNOLOGY 2012-2022 ($ MILLION)
4.1. ION Semiconductor Sequencing
4.2. Pyrosequencing
4.3. Sequencing By Ligation (SBL)
4.4. Sequencing By Synthesis (SBS)
4.5. Single-Molecule Real-Time Sequencing (SMRT)
4.6. Other

5. GLOBAL NEXT GENERATION SEQUENCING MARKET REGIONAL OUTLOOK 2012-2022($MILLION)
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Middle East & Africa
5.5. Latin America

6. COMPANY PROFILE
6.1. Life Sciences Corporation (Roche Holding Ag)
6.2. Agilent Technologies, Inc.
6.3. Beijing Genomics Institute
6.4. Eurofins Scientific
6.5. Gatc Biotech Ag
6.6. GEHealthcare
6.7. Illumina, Inc.
6.8. Macrogen Inc.
6.9. Newgene Ltd.
6.10. Novartis
6.11. Oxford Gene Technology
6.12. Oxford Nanopore Technologies
6.13. Pacific Biosciences Of California, Inc.
6.14. Perkinelmer, Inc.
6.15. Qiagen N.V.

Global Next Generation Sequencing Market is expected to grow at the CAGR of 21.2% during 2015-2022 – Brisk Insights reviewed on July 6, 2016 by rated 4.9 of 5

Release ID: 2170

About Monica Samuel

Check Also

400-400

Global Carbon Nanofiber Market Size, Share, Growth, Outlook, strategies and Forecast to 2016: Acute Market Reports

Notes: Production, means the output of Carbon Nanofiber Revenue, means the sales value of Carbon ...